The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Wnt addiction of genetically defined cancers reversed by PORCN inhibition
Open accessAbstract
Enhanced sensitivity to Wnts is an emerging hallmark of a subset of cancers, defined in part by mutations regulating the abundance of their receptors. Whether these mutations identify a clinical opportunity is an important question. Inhibition of Wnt secretion by blocking an essential post-translational modification, palmitoleation, provides a useful therapeutic intervention. We developed a novel potent, orally available PORCN inhibitor, ETC-1922159 (henceforth called ETC-159) that blocks the secretion and activity of all Wnts. ETC-159 is remarkably effective in treating RSPO-translocation bearing colorectal cancer (CRC) patient-derived xenografts. This is the first example of effective targeted therapy for this subset of CRC. Consistent with a central role of Wnt signaling in regulation of gene expression, inhibition of PORCN in RSPO3-translocated cancers causes a marked remodeling of the transcriptome, with loss of cell cycle, stem cell and proliferation genes, and an increase in differentiation markers. Inhibition of Wnt signaling by PORCN inhibition holds promise as differentiation therapy in genetically defined human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
TRANSFAC(R): transcriptional regulation, from patterns to profiles
Matys, V. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg108 · Cited by 1,985
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
The complex world of WNT receptor signalling
Niehrs, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3470 · Cited by 1,492
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors
Koo, B.-K., Spit, M., Jordens, I., Low, T. Y., Stange, D. E., van de Wetering, M., van Es, J. H., Mohammed, S., Heck, A. J. R., Maurice, M. M., et al. (2012) · Nature · doi:10.1038/nature11308 · Cited by 980
ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner
Hao, H.-X., Xie, Y., Zhang, Y., Charlat, O., Oster, E., Avello, M., Lei, H., Mickanin, C., Liu, D., Ruffner, H., et al. (2012) · Nature · doi:10.1038/nature11019 · Cited by 972
Recurrent R-spondin fusions in colon cancer
Seshagiri, S., Stawiski, E. W., Durinck, S., Modrusan, Z., Storm, E. E., Conboy, C. B., Chaudhuri, S., Guan, Y., Janakiraman, V., Jaiswal, B. S., et al. (2012) · Nature · doi:10.1038/nature11282 · Cited by 960
Structural Basis of Wnt Recognition by Frizzled
Janda, C. Y., Waghray, D., Levin, A. M., Thomas, C., & Garcia, K. C. (2012) · Science · doi:10.1126/science.1222879 · Cited by 875
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
Emami, K. H., Nguyen, C., Ma, H., Kim, D. H., Jeong, K. W., Eguchi, M., Moon, R. T., Teo, J.-L., Oh, S. W., Kim, H. Y., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404875101 · Cited by 874
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 831
Tsukamoto, A. S., Grosschedl, R., Guzman, R. C., Parslow, T., & Varmus, H. E. (1988) · Cell · doi:10.1016/0092-8674(88)90220-6 · Cited by 747
Wu, J., Jiao, Y., Dal Molin, M., Maitra, A., de Wilde, R. F., Wood, L. D., Eshleman, J. R., Goggins, M. G., Wolfgang, C. L., Canto, M. I., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118046108 · Cited by 640
Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120068109 · Cited by 614 · cited 3×
“9,17 Consistent with this hypothesis, there was massive remodeling of the transcriptome in RSPO-overexpressing CRC xenografts within 3 days of treatment.”
Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
Takahashi-Yanaga, F., & Kahn, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2943 · Cited by 499
Exome sequencing of liver fluke–associated cholangiocarcinoma
Ong, C. K., Subimerb, C., Pairojkul, C., Wongkham, S., Cutcutache, I., Yu, W., McPherson, J. R., Allen, G. E., Ng, C. C. Y., Wong, B. H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2273 · Cited by 486
Self-citationRNF43 is frequently mutated in colorectal and endometrial cancers
Giannakis, M., Hodis, E., Jasmine Mu, X., Yamauchi, M., Rosenbluh, J., Cibulskis, K., Saksena, G., Lawrence, M. S., Qian, Z. R., Nishihara, R., et al. (2014) · Nature Genetics · doi:10.1038/ng.3127 · Cited by 470
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
Jiang, X., Hao, H.-X., Growney, J. D., Woolfenden, S., Bottiglio, C., Ng, N., Lu, B., Hsieh, M. H., Bagdasarian, L., Meyer, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307218110 · Cited by 414
Three decades of Wnts: a personal perspective on how a scientific field developed
Nusse, R., & Varmus, H. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.146 · Cited by 412
Proffitt, K. D., Madan, B., Ke, Z., Pendharkar, V., Ding, L., Lee, M. A., Hannoush, R. N., & Virshup, D. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2258 · Cited by 382
Self-citationA Wnt Survival Guide: From Flies to Human Disease
Chien, A. J., Conrad, W. H., & Moon, R. T. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.445 · Cited by 376
An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription.
Lam, E. W., & Watson, R. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05932.x · Cited by 342
GATHER: a systems approach to interpreting genomic signatures
Chang, J. T., & Nevins, J. R. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl483 · Cited by 321
Noncompartmental Analysis Based on Statistical Moment Theory
(1982) · Drugs and the Pharmaceutical Sciences · doi:10.1201/b14095-12 · Cited by 288
Xenome—a tool for classifying reads from xenograft samples
Conway, T., Wazny, J., Bromage, A., Tymms, M., Sooraj, D., Williams, E. D., & Beresford-Smith, B. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts236 · Cited by 276
WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification
Coombs, G. S., Yu, J., Canning, C. A., Veltri, C. A., Covey, T. M., Cheong, J. K., Utomo, V., Banerjee, N., Zhang, Z. H., Jadulco, R. C., et al. (2010) · Journal of Cell Science · doi:10.1242/jcs.072132 · Cited by 215
Self-citationReciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation
Fu, J., Jiang, M., Mirando, A. J., Yu, H.-M. I., & Hsu, W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904894106 · Cited by 196
Dhawan, P., Ahmad, R., Chaturvedi, R., Smith, J. J., Midha, R., Mittal, M. K., Krishnan, M., Chen, X., Eschrich, S., Yeatman, T. J., et al. (2011) · Oncogene · doi:10.1038/onc.2011.43 · Cited by 180
Safely targeting cancer stem cells via selective catenin coactivator antagonism
Lenz, H., & Kahn, M. (2014) · Cancer Science · doi:10.1111/cas.12471 · Cited by 175
Stearoyl CoA Desaturase Is Required to Produce Active, Lipid-Modified Wnt Proteins
Rios-Esteves, J., & Resh, M. D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.027 · Cited by 166
Najdi, R., Proffitt, K. D., Sprowl-Tanio, S., Kaur, S. J., Yu, J., Covey, T. M., Virshup, D. M., & Waterman, M. L. (2012) · Differentiation · doi:10.1016/j.diff.2012.06.004 · Cited by 153
Self-citationThe Soluble Wnt Receptor Frizzled8CRD-hFc Inhibits the Growth of Teratocarcinomas In vivo
DeAlmeida, V. I., Li, M., Ernst, J. A., Koeppen, H., Polakis, P. G., & Rubinfeld, B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0266 · Cited by 139
Precise Regulation of Porcupine Activity Is Required for Physiological Wnt Signaling
Proffitt, K. D., & Virshup, D. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.381970 · Cited by 131
Self-citationHannoush, R. N., & Arenas-Ramirez, N. (2009) · ACS Chemical Biology · doi:10.1021/cb900085z · Cited by 130
RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary
Ryland, G. L., Hunter, S. M., Doyle, M., Rowley, S. M., Christie, M., Allan, P. E., Bowtell, D. D. L., Chenevix‐Trench, G., Gorringe, K. L., & Campbell, I. (2012) · The Journal of Pathology · doi:10.1002/path.4134 · Cited by 126
Targeting Wnts at the Source—New Mechanisms, New Biomarkers, New Drugs
Madan, B., & Virshup, D. M. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-1038 · Cited by 115
Self-citationThe Development of Highly Potent Inhibitors for Porcupine
Wang, X., Moon, J., Dodge, M. E., Pan, X., Zhang, L.-S., Hanson, J., Tuladhar, R., Ma, Z., Shi, H., Williams, N. S., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400159c · Cited by 107
Yu, J., & Virshup, D. M. (2014) · Bioscience Reports · doi:10.1042/bsr20140119 · Cited by 73
Self-citationCoombs, G. S., Schmitt, A., Canning, C. A., Alok, A., Low, I. C. C., Banerjee, N., Kaur, S. J., Utomo, V., Jones, C. M., Pervaiz, S., et al. (2011) · Oncogene · doi:10.1038/onc.2011.228 · Cited by 70
Self-citationLum, L., & Clevers, H. C. (2012) · Science · doi:10.1126/science.1228179 · Cited by 64
RSPO fusion transcripts in colorectal cancer in Japanese population
Shinmura, K., Kahyo, T., Kato, H., Igarashi, H., Matsuura, S., Nakamura, S., Kurachi, K., Nakamura, T., Ogawa, H., Funai, K., et al. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3409-x · Cited by 59
Membrane targeting of palmitoylated Wnt and Hedgehog revealed by chemical probes
Gao, X., Arenas-Ramirez, N., Scales, S. J., & Hannoush, R. N. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.06.033 · Cited by 45
Gurtner, A., Fuschi, P., Martelli, F., Manni, I., Artuso, S., Simonte, G., Ambrosino, V., Antonini, A., Folgiero, V., Falcioni, R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0721 · Cited by 41
Abstract 2408: Identification of R-Spondin fusions in various types of human cancer
Cardona, G. M., Bell, K., Portale, J. C., Gaffney, D. S., Moy, C. H., Platero, S. J., Lorenzi, M. V., & Karkera, J. D. (2014) · Cancer Research · doi:10.1158/1538-7445.am2014-2408 · Cited by 6
Cited by
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
Targeting the Wnt/β-catenin signaling pathway in cancer
Zhang, Y., & Wang, X. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00990-3 · Cited by 1,431
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
Dienstmann, R., Vermeulen, L., Guinney, J., Kopetz, S., Tejpar, S., & Tabernero, J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.126 · Cited by 1,021
Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target
Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01616-7 · Cited by 857
Metadata
- Authors
- Madan, B., Ke, Z., Harmston, N., Ho, S. Y., Frois, A. O., Alam, J., Jeyaraj, D. A., Pendharkar, V, Ghosh, K., Virshup, I. H., Manoharan, V, Ong, E. H. Q., Sangthongpitag, K., Hill, J., Petretto, E., Keller, T. H., Lee, M. A., Matter, A., & Virshup, D. M.
- Venue
- Oncogene
- Published
- 2015-08-10
- Volume
- 35
- Issue
- 17
- Pages
- 2197-2207
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1900557155
- Cited by
- 341
- References
- 48
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.